原廠-Dxs
DxS has developed a range of tumour analysis products that detect mutations in EGFR, RAS, RAF and other genes associated with cancer drug responses.

原廠-Genomic Health
The first diagnostic assay developed by Genomic Health — Oncotype DXR — is a breast cancer test that may assist treatment planning by quantifying the likelihood of distant breast cancer recurrence.